: *
.
[email protected]: #$ !"
!
" # "
*
1
1 -
!
" # $ % " & ' () $ *+
.
! / #
$ % / #
2 / '( ) 96
/ ,' ' 72
: 8 / 1 / 96 :
6 / 3 / 96
:
! "
#$
% . '( )* +!), ( -). / 0 )* 1)
2 )3
4 2 3 5 ( 0 6*
. / 7 8 89 : 7 0 2
*;
)
(< = ( < $ 7. 0 > = .
? ( <
:
10 < $ 7. <6 5
) 0 )B B< * ' C ( ( B D ' CE 0% / 1F = ( <6
/<
100
< G ( D H 7 8 1F I 9 G J KL$ FID
I
<6 1 B M 9 % ( <
.
:
5 ( ><6L * ( ( / E N (
7.
<) $ 5 / 2 3 ± / 4 ) ) )5 ( ><)6L
> = 7 / 4 6 ± / 47
= ( 7. ( 5 ( ><6L
1 / 0 3± / 0 > = 5 ( ><6L 4
/ 6 7 ± / 40 )
1 ( % .
L UV B
:
) 0 W 5 ( D X <B = ( < $ 7.
)# > =) Y
7 ) )#
6 W ' * 2 3 ( ( M , =ZM
( .
'4 Z*
:
B< * 0 B I = ( I < $ 7. I .
1 :-#
1 2 ;< = <' <7*> < ? +
@ A - < B (C 6! 5 8 1 2
) 1 ( . C < F7 '- G ; + ;-7> * +
6#
H I%
<# < G J <:-#
1 <2 K< 6<#
1 :-#
1 2 7*>
> + LM # . < / <0 -<
F
6 # -N F ;' & O- 5
5 1 2
;-<P # C "G -2 )
(COOH
<#
" 6 ;<I <
) 2 .(
@ J
# 0 1 2 R 9 I
<<
" <<5 / <<0 1 2 -<< J 7<< / <<0 1 2 -<< 6<<#
- J 7 / 0 1 2 - 6 C # F 1 J 7 -
# 0 1 C
6 4 5 / 0 1 2 - .
6:2 C 5 1 2 6*- 6# / 0 - # -N .#
P = F5 1 2 -)
) (C-C
<' 6#
< ;<I
<- J 7 #( / 0 - # <
<
) 3 .(
2 -
# P* T (9 U+ # J 7 / 0 1
) ( LDL
8 .-+
T2
/ % P*
) (HDL
<
<
6N-
T (9 $ 5 P*
2 . 1 2 - / 0
4 5 # V+
-LW5 # X 1 :-#
1 2 N U+ # 7*>
1 :-#
2 J < ;-7>
" Y <
<2
<
<
1G <<&
<<'*:+ V <<% <<#
? <<+ $ -*5 <<
C ) 4 5 .(
@ < -) \<7Y <9 FDA
1 2 -<
P # 4 5 / 0 : 6#
1 9 < 1G < 3
# T2 ) 6 .(
1 2 - 4 5 / 0 6#
Y <!-7Y
7& ^= I_ C 6#
`< C C
<R " C a<
<-& !9 ;<3 8 6<
1 #
1 2 " C a< <! R <
< # .
1 2 - 4 5 / 0 .- b:2
.<
<2 <# 0 <2
9 Y " - G -2
. 1 2 2 -C <R 6<#
< R 6<:- $ <9 6# 2 -C . & 8 . 6 1 C < T (<9 O7< < .< < ; 75 .<
C 6-`I5 Y .- b:2 .<
1 <2 2 <-C
# 6*8 1 c (-
1 2 - 4 5 / 0 <-& 5
C ) 8 7 .(
' -8 .
# 0 1 2 G @
1 2 # R 1 - #
. 1 8 . .
= # c
1 2 - J 7 / 0 < #
. " (<- .<
8 59
% " <R / <0 1 2 -< ; <
.
-<< F h << X i << 6<<# J 7<< / <<0 1 2 -<<
) 18:0 (C $ < <P* lm T (9 U+ # <
< C
) 9 .(
6 " ! F G & - -) ^ !& m
<<: 8 T (<<9 " (<<- 1 <<:-#
1 <<2
<<> + <<7*>
<<#
# 0 1 2 (- -# 4 5 1 6< <
-LW<5
n .-h5 ) o-&
2 T-) -#
<
<
) 10 .(
<
1999 : $V+FDA
4 5 / 0 1 2 - " (- 6
< p OP0 # #
) 11 .(
^ <!& m
q <<I .-<<# <<7i 6<m# (<<- 1 <<! F G & - <-)
# J 7 4 5 / 0 1 2 - 1 :-#
1 2
*>
> + 7
B (C )
12 .(
T2 5 1G < 9 1 3
<8 T2 U+ # J 7 / 0 1 2 - 42
1 <3
" (- 1 :-#
1 2
> + 7*>
8 6 &
m% " (- T2 1 :-#
1 2
> + 7*>
1 # 2 3
9 --r5
# 0 1 2 4 5 53 < <# <3
) 13 .(
5
J 7< / 0 1 2 - s !5 6 6-3
# 4 5 .
1 2 / <0 1 2 -
J 7< -
6# V # : 8 T2 6 C # F # 1 <:-#
1 <2
> + 7*>
<# 0 q <I " (- T2 5 LM -P#
# 2 % )
14 .(
# 0 1 2 .-h5 ) o-& " (- 4 5
a
P*
LDL
" % T (9
6< < 2 t= <: 8
6#
Y
= # 7*> 1 :-# m% ;c P #
# 0.
1 2
? <<+ << / <<@ & <<N U<<+ # .-<< b:2 4 <<5 uV<) <N (<- .<
<# 0 1 <2
P A T<c O<*> <% 1 2 <
) 15 16 .(
6<7
$ 6-8 -%v # 0 ` C
# . (<- 6<7
^ < (C 6< < 0 2 # < 2 1 1(o
T2 < 6 C 6# 7P " q I 6 " 8 (R 2 # 6 9 X
. 2
# 0 1 2 n!# 9 I
% <2 <
< # ) 17 .(
< # <2 1 <# 6<
. 1 2 9 C ^ 3 # R 6 " w 6
1 8 1 2 -
# 1 n / 0
. 6<# 6<R 5 #
67 -8 . q I .
1 2
1 & " ^ +VY " # 1 2 -
.< / <0
< x- ^ r-*75 *+ 6# .- b:2 9 J <# <@ n L 1 <:-#
1 <2 <> + <7*>
) 18 ( .<
1 & # y 6# 6!& m 1 2 -
4 <5 / <0
" < & " < 9 <I 6<7 -8 . R 9 C ^ 3 .
? ( <
`-<3 5 B 6<<# 6<!& m .<
1 <#
15 6<< :
67 -8 . )
10 .< 6< : 5
6<7 6< : (
9 C $ N " -& 5 .
6 : 2 6#
Y 9 <I5
-& 5 ( )
2 +
(
" @ 1 2 "
1 & ` C K " &
x:R 1 . 6 : 2 4)
x:R 1 6#
^ 3 tV
; < < 6#
z< 5 < c ! <
)AOCS American Oil Chemists Society
( ;<-
1 2 - R / 0 6 :
2 -8 . 1
6-@5 67 .
" <2 6<# 4<) 6< O<-5 5 . #
" % ' 6 :
2 6< : 2 $ C F 6 < #
;<c T < 6<& & F< " 6<# ) o-) z 5 C . 4o 7
*- -&
" V8 2
" ( 2 <*- < -&
< 6 P# '_ 6& & / (9 " 6# & ) B <R 1 < .<# " T < 6<& & 2 6# / % 55 - 50 6R C
^ < 6<#
15 <> 6<c->
. 4) 15 ^ < 6<# T < 6<& & 6<c->
5 6<c->
6# \ (5 1 # 9 6 6 .
<C
` 9 C 5 .
<*_ ` < <# 4o<
6 / 0 - y*
1 <2 6 % < {a<
/ <0 -< <3 < " - 7-& _ 6 : R 1 -C
<
. 6< : <2 1 <#
3 <#
@ 3 $ N ? 9 ;8
6#
^ 3 .- - 3
B (C + .
)) K ))[ \ )) 0 ))B ' C )) ( )) '
B< * :
6 a C 6-& 1 190
6R <
<C
6< a C < ) 1 215
6<R <
<C
<< 6<< a C << ) 1 << 1 C << " <<
10
T (9 + 6c->
5 / 1 6R C
6c->
'5 1 250
6R <C
\< (5 1 <
250
6R C
< 6<# \ (5 N8 1 7P
100 / 1
; 8 C 9
8 / 0 <*- <
<N8 6<c->
\ (5 1 -& '- # ) 19 (.
-< <2 ;<3 8 <-! q _ :2 6# .- - <3 .- b:2 / 0 1 2 -<
<3 J 7< / <0
2 - 1 4 5 / 0 15
` # 6 :
$ (<9
1
SPSS
6#
^ 3 6} B (C .
# w 6#
; 9 ) 1 2 -
/ <0
. -8 O-5 5 6#
# - F<- & -&
7 / 0
±
26 / 1 - F-h& -&
7 / 0 28± / 2 -<
F<-h&
5 / 2
±
1 / 29 - h <
F 16 / 1 25± / 8 -<
F -<
05 / 0 14± / 0 F- -:& ) -<<<<
9 / 3 63± / 23 -<<<<
F<<<-h& -:& ) 4
/ 0 7± / 0 F-h& <<<P -<<<
4 / 1
±
75 / 3 - F- <P 8 / 1 5± / 11 -<
F< &
2
±
18 / 4 4 <<5 F<<-h& -&
-<<
3 / 1 28± / 5 4 <<5
F <<-}=
-<<
05 / 0 14± / 0
$ <<C 100
$ <<C
<<#
)
; 9 1 2 - / 0 67
. # ^ <3 <#
-<
F- & -&
6 / 0 98± / 0 - F-h& -&
7 / 0 7± / 1 -<
F-h&
8 / 5 44± -<
F h <
5 / 5 3± / 17 -<
F - 0 1± / 0 F- -:& ) - 8
/ 0 28± / 17 -<
F-h& -:& ) 1
1± / 2 -<
F-h& <P 6
/ 0 16± / 1
-<<
<<P - F 1 5± / 4 -<<
F<< &
5 / 0 06± / 1
4 5 F-h& -&
-<
05 / 0 16± / 0 4 <5 F <-}=
- 05 / 0 16± / 0
$ C 100
$ C # . w .- b:2
" <<
6<<
.<<
1 <<2 <<-8 1
7 / 4 6± / 47
J :N 3 1 2 - / 0 J 7 5 / 2 3± / 4 J :N
3 1 2 - / 0 4 5 <P2 6< :
<2 1 6<7
1 8 4 / 6 7± / 40 J :N 3 1 2 - / 0 J 7
.- b:2 1
/ 0 3± / 0 J :N 3 1 2 - / 0 4 5
#
" (- J :N 1 2 - / <0 J 7<
4 <5
. -8 9 / 3 9± / 51 3 6<7
5 / 6 9± / 40
3 # .
UV L
B
1 :-#
1 2 > + 7*>
;*+
x A -
< ? + *' 5 N # 6 C 9 " 9 -) R 6#
. 6< m < --r5 2 6<#
1 <<5 <<P* lm<< T2 << O<<R << # 1 <<_
*C -<<<P- <<< <<< :<<< V) <<< <<< ^ v
" - -P
-C
1 -C *RLDL
<
<
< 5 <
" <<<
5 9 <<< -) -<<<
1 -C <<<*R *'<<<
1 :-#
1 2
# 6 Tc > + 7*>
. " ^ !& m
2
-C
< c U<+ # -< F-h& LDL -C
" - -P ;# c LDL
<
<
) 20 .(
.<
1 <2
J 7< / 0 1 2 - = # " (- 1 8 # <- <<*7> ^ <<!& m 6<< < # (
z<< 5 6<<
.-5 <<
" ':2 # 6 9 C ^ 3 J 7< / <0 1 2 - " (-
8 59 3
# < < C 6<
\<-c_5
6< <# < -# $ N " & " 6 ~ 8 " (- "
1 2 - <-8 . J 7 / 0 7
/ 4
±
6 / 47 <<3 6<< :
<<2 6<<7 1 4 / 6 7± / 40 <<3
# ) 21 .(
^ <3 < 2 < 6< 5 <c-c_5 6< -< 6N- . 6# 9 C
<-!:R 1 <2 6<9
+ : R 1 I >
2 @<
1 A (<#
" < @ <2
q I .
1 2 J -< <-8 1 <:-#
1 <2 <7*>
Tc > + )
23 22 .(
J 7 / 0 1 2 - s !5
/ <0 1 2 -< # 4 5 -
J 7<
" (<- T2 <
F<P (<<- $ < <P* LDL
1 <<:-#
1 <2 <<7*>
> + < <# 0 q I " (- T2 5 LM -P#
.
6#
^ <3 < -# 6< < < 6-<3 5 <
30 %
< - ^ 3 # 0 q I \ Y 1G 9 2000 1 6# ' O*> .:N q <8
30 % $ <C
#
: 8 T2 y 6# 6 : 6-3 5 6
6# 1V # 1 :-#
1 2
> + 7*>
q <I T2 1 R 6#
J << <<# 4 <<5 J 7<< / <<0 1 2 -<< << # <<# 0 C s !5 J 7 - )
24 .(
.< $ <N 6' 6# 6R 5 #
1 & •V3 6# N ^ --r5 .-h5 ) o-&
1 2
q <I K< 6<# 2 < 1 -P# 2 % $ 6 9 T2 @R 5 ;# > " (- 6# 4 5 / 0 1 2 -
. # 1 ) ~ 8 8 <8
5 / 0 <&
1 / 2
4 5 / 0 1 2 - q I \ Y 6 1G 3
.- W<<5
<<
<<
) 25 .(
<<c-c_5 6<<
<<
2002
" ':2 1
# ^ L 1 .
<2 <# 0 <2 <#
1
&
1 2 -o- 6< - 6N- . 6# 6 $
;-*_5 6 (N5 4) 1 2 -
<-8 .< / 0
8 8 / 47 3 1 2 -<
J < / <0 1 2 -<
# J 7 / 0
) 26 (.
6 ~ 8 \-c_5
6 9 C ^ 3 " & "
(- "
1 2 -<
/ <0
<-8 . R J 7 7
/ 4 6± / 47 <3
6 : <2 6<7 1 4 / 6 7± / 40 6< <# <3 t<7 c5
<#
@# << ? <<9 \<<-c_5 .
1= <<# " (<<- 6<<# 6<<R 5 <<#
A - z 5 1 <:-#
1 <2 < 2 <> + <7*>
-!:R 1 <2 " <':2 € -< < 1 @<
2 1 # 5 c-c_5 .<
1 <2 < <-8
1 :-# J - 6 - 6N- . 6# $ N 67 J . q I 6 1 9 > + 7*>
. <2
5= # P2 )
27 .(
" (- 1 2 - 4 5 / 0
Y -8 . 7
z< 5 < $V+ w \ <8FDA
`3 # ) 28 ( • " (<- 6<!& m .<
1 2 -<
6<R 5 ;# > c 6# 67 -8 . 4 5 / 0 <<-` ^ <<L <<# << 7 1 2 << 6<<0 <<C <<R
1 2 - 4 5 / 0 6#
<
" C a<
R V #
& 6#
;- . 6' .
2 1
2 = # c
1 2 - q <I P2 J 7 / 0
< 6-3 5 8 T-#
<
<P # <C (<-2 ) )
17 .(
< l-_<3 q <I €< 2 9 w 5 .
( <R ; <
. 1 2 x -`
. 1 R 6#
67 -8 (<-2 )
/ <0 1 2 <<8 T-# q I B <
` <
.< J < 1 # < l-_<3 <# 0
<2 \ < 5
& 5
" C << - <<-& 5 6<<# .<< x <<3
.<<
1 <<2 <<#
" -<< = 9 H <<% 6<< 9 7@#
r5 6<<
1 / <<*m
9 < y < <# <-& !9 $ <N 6<# $ < \ 5
@# Ta# ‚ ƒ .
( M GE
< 1 < 9 ^ <c-c_5 < ! 6*- . # " & ' () $ *+
& 6#
-
; :8 ? <9 • Y &
< 1 > / R -2 <#
• <Y $ < _ ƒ < <8V9
< < ! < "
' 5
>
C .
References
1. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, et al. Dietary hydrogenated fat increases high- density lipoprotein apoA-I catabolism and decreases low density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Arterioscler Thromb Vasc Biol. 2004;
24(6): 1092-1097.
2. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, et al.
Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005;
135(3): 562-566.
3. Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest. 2005; 127(6): 2254-2263.
4. Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD. Trans-fatty acids and colon cancer. Nutr Cancer. 2001; 39(2): 170-175.
5. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med.
2006; 354(15): 1601-1613.
6. Micha R, King IB, Lemaitre RN, Rimm EB, Sacks F, Song X, et al. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr. 2010; 91: 883-893.
7. De La Torre A, Gruffat D, Durand D, Micol D, Peyron A, Scislowski V, et al. Factors influencing proportion and composition of CLA in beef. Meat Sci. 2006; 73(2): 258- 268.
8. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006; 48(4): 677-685.
9. Fernandez ML, West KL. Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr. 2005; 135(9): 2075-2078.
10.Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr.
2009; 63: 5-21.
11.Food and Drug Administration, HHS. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist. 2003;
68(133): 41433-41506.
12.Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr. 2009;
63: 22-33.
13.Oomen CM, Ocke MC, Feskens EJ, van Erp-Baart MA, Kok FJ, Kromhout D.
Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001;
357(9258): 746-751.
14.Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr.
2001; 20(1): 5-19.
15.Ghafoorunissa G. Role of trans fatty acids in health and challenges to their reduction in Indian foods. Asia Pac J Clin Nutr. 2008;
17: 212-215.
16.Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;
77(5): 1146-1155.
17.Rawashdeh AYA. Influences of olive oil and ghee (samen balady) on serum cholesterol of Jordanians. Paki J Nutr. 2002;
1(6): 270-275.
18.Gebauer SK, Psota TL, Kris-Etherton PM.
The diversity of health effects of individual trans fatty acid isomers. Lipids. 2007; 42(9):
787-799.
19.Preparation of Methyl Esters of fatty acids, AOAC Official Method Ce2-6. 5th ed.
Reapproved 1997.
20.Kromhout D, Menotti A, Kesteloot H, Sans S. Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation. 2002; 105(7): 893-898.
21.Martin CA, Milinsk MC, Visentainer JV, Matsushita M, de-Souza NE. Trans fatty acid forming processes in foods: a review.
An Acad Bras Cienc. 2007; 79(2): 343-350.
22.Raheja BS. Dietary fats and habits and susceptibility of Asian Indians to NIDDM and atherosclerotic heart disease. J Diabet Assoc India. 1991; 31: 21-28.
23.Djurhuus M, Henriksen J, Klitgaard N, Beck-Nielsen H, Raheja B, Mckeigue P, et al. Obesity and coronary risk factors among South Asians. The Lancet. 1991; 337(8747):
971-972.
24.Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr.
2001; 20(1): 5-19.
25.Dashti N, Feng Q, Freeman MR, Gandhi M, Franklin FA. Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells. J Nutr.
2002; 132(9): 2651-2659.
26.Dwivedi C, Crosser AE, Mistry VV, Sharma HM. Effects of dietary ghee (clarified butter) on serum lipids in rats. J Appl Nutr. 2002; 52: 65-68.
27.Singh RB, Niaz MA, Ghosh S, Beegom R, Rastogi V, Sharma JP, et al. Association of trans fatty acids (vegetable ghee) and clarified butter (Indian ghee) intake with higher risk of coronary artery disease in rural and urban populations with low fat consumption. Int J Cardiol. 1996; 56: 289- 298.
28.AOCS Official Method Ce. Preparations of methyl esters of fatty acids. 1997; 2-66.
Evaluation the rate of trans fatty acids isomers in ghee and tail sheep consumption in Lorestan
Hedayatifar R*1
1. MSc of toxicology, Food Control Lab, Food and Drug Deputy of Lorestan University of Medical Sciences, Khorramabad, Iran, [email protected]
Received: 28 March 2017 Accepted: 27 May 2017
Abstract
Background: Trans fatty acids are known as the most harmful type of dietary fats. Food and Drug Administration (FAD) has announced that TFAs consumption should be reduced to less than 1% of energy consumption. The aim of this study was to compare the amount of fatty acids with emphasis on trans fatty acids of ghee (animal oil) and tail sheep.
Materials and Methods: 10 samples of ghee and 5 samples of tail sheep were transformed into methyl ester and analysis of fatty acid methyl esters were performed by gas chromatography (GC) with 100 meter capillary column and flame ionization detector (1µ lit injected to GC).
Results: Results show that total trans fatty acid in tail sheep samples were 4.3 ± 2.5 and total saturated fatty acid were 47.6 ± 4.7 g/100g fat, and in ghee oil samples were 0.3 ± 0.1 and 40.7 ± 6.4 g/100g fat, respectively.
Conclusion: Ghee and tail sheep contains high percentage of saturated fatty acids including trans and saturated fatty acids. Therefore, people who consume these foods may put themselves at elevated risk of cardiovascular disease.
Keywords: Trans fatty acids, Ghee, Tail sheep, Gas chromatography.
*Citation: Hedayatifar R. Evaluation the rate of trans fatty acids isomers in ghee and tail sheep consumption in Lorestan.
Yafte. 2017; 19(2): 1-8.